In an article posted by MITnews.com, Stefanie Koperniak describes a new paper written by Christopher L. Magee, professor at MIT, and David Broniatowski, professor at Johns Hopkins University. The paper, “Does Seating Location Impact Voting Behavior on FDA Committees?” will be published in the July issue of The American Journal of Therapeutics, and will analyze that very question. Both authors believe that although panels should reflect objectivity, there is still a human nature component. Do you think that seating location can have such impact? Read the full article here.
Obstacles Facing Biosimilars
Still in its infancy in the U.S., the industry faces some growing pains.
Life Science Accelerated
Our experts are dedicated to expediting life science product development regulatory pathways.